Is Ceapro Inc. (CRPOF) a Buy, Sell, or Hold?
OTC : CRPOF
Ceapro Inc.
$0.17 USD
-$0.03 (-13.04%)
- Volume
- 6K
- Average Volume
- 557
- Market Capitalization
- $13.31M
- P/E Ratio
- -3.74
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.40
- Year Low
- $0.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.54
Company Overview
OTC
Gilles R. Gagnon
Biotechnology
Healthcare
CRPOF
N/A
CA
USD
Liquidity Metrics
0.08
8.54
5.49
5.09
0.00
Sales & Valuation
$9.63M
0.07
0.63
-0.15
-0.06
Profitability
-$0.0602
-$4.71M
-48.89%
-61.29%
-15.66%
-14.98%
P/E Metrics
-3.74
0.04
0.04
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
3.32
2/9
$10.22M
$29.41M
$3.43M
-$7.77M
Key Metrics (TTM)
-$5.91M
-0.61
1.54
8.54
-15.66%
-16.57%
-26.74%
-668.29%
253 days
Company Executives
| Name | Title |
|---|---|
| Bernhard Seifried | Senior Director of Research & Technology |
| Gilles R. Gagnon | Chief Executive Officer, President & Director |
| Michel Regnier | Senior Vice President of Technical Operations |
| Stacy Prefontaine | Chief Financial Officer & Corporate Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Ceapro Inc. (OTC:CRPOF) Stock
Operating as a biotechnology enterprise, Ceapro Inc. is dedicated to pioneering and bringing to market health and wellness offerings, alongside their underlying technologies, which are all predicated on plant-derived compounds. Its commercial reach extends across the United States, Germany, China, Canada, and various other global markets. The company's operations are divided into two principal sectors. The first, its Active Ingredient Product Technology division, is centered on inventing and employing exclusive extraction methodologies. These are utilized for the manufacturing, refinement, and sale of potent substances like oat beta glucan and avenanthramides, extracted from oats and other sustainable botanical sources, serving both the healthcare and beauty industries. Conversely, the Cos ... meceutical Industry segment concentrates on the creation and commercial release of anti-aging goods. These products, formulated from natural active components, are primarily distributed straight to consumers through the company's online portal and via a network of specialized natural product retailers. Established in 1997, Ceapro Inc.'s main corporate office is located in Edmonton, Canada.
Frequently Asked Questions
-
What is the current Ceapro Inc. (CRPOF) stock price?
-
Ceapro Inc.(OTC:CRPOF) stock price is $0.17 in the last trading session. During the trading session, CRPOF stock reached the peak price of $0.399 while $0.115 was the lowest point it dropped to. The percentage change in CRPOF stock occurred in the recent session was --13.04% while the dollar amount for the price change in CRPOF stock was -$0.03.
-
CRPOF's industry and sector of operation?
-
The OTC listed CRPOF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CRPOF?
-
Bernhard Seifried | Senior Director of Research & Technology
Gilles R. Gagnon | Chief Executive Officer, President & Director
Michel Regnier | Senior Vice President of Technical Operations
Stacy Prefontaine | Chief Financial Officer & Corporate Secretary
| -
How many employees does CRPOF have?
-
Number of CRPOF employees currently stands at None. CRPOF operates from 7824 – 51 Avenue NW, Edmonton, AB T6E 6W2, CA.
-
Link for CRPOF official website?
-
Official Website of CRPOF is: https://www.ceapro.com
-
How do I contact CRPOF?
-
CRPOF could be contacted at phone #None and can also be accessed through its website. CRPOF operates from 7824 – 51 Avenue NW, Edmonton, AB T6E 6W2, CA.
-
How many shares of CRPOF are traded daily?
-
The average number of CRPOF shares traded daily for last 3 months was 557.
-
What is the market cap of CRPOF currently?
-
The market value of CRPOF currently stands at $13.31M with its latest stock price at $0.17